Many biomarkers clinically used for cancer diagnosis are also glycoproteins, such as prostate-specific antigen in prostate cancer15; Her2/neu in breast cancer16; CA-125 in ovarian cancer17; and CEA in colorectal, breast, pancreatic, and lung cancer.18 This evidence concerns the gene ERBB2 and cancer.